The orthomolecular treatment of cancer: III. Reticulum cell sarcoma: Double complete regression induced by high-dose ascorbic acid therapy

doi:10.1016/0009-2797(75)90007-1

Chemico-Biological Interactions

Volume 11, Issue 5, November 1975, Pages 387-393

https://doi.org/10.1016/0009-2797(75)90007-1 Get rights and content

Abstract

The response of a patient with histologically proven reticulum cell sarcoma to no treatment other than large doses of ascorbic acid is described. At the time of first diagnosis, the disease was widely disseminated, and a very dramatic regression of all parameters of disease activity was induced by the continuous administration of large doses of ascorbic acid. Reduction in dosage some months later coincided with reactivation of the disease process. The reinstitution of regular high-dose ascorbic acid therapy induced a second complete remission. The case report is illustrated by serial radiographs. The significance of the therapeutic response is briefly discussed in relation to general schemes of cancer management.

References (6)

CameronEwan et al.
Ascorbic acid, cell proliferation and cancer
Lancet
(1972)
CameronEwan et al.
The orthomolecular treatment of cancer, I. The role of ascorbic acid in host resistance
Chem.-Biol. Interact.
(1974)
CameronEwan et al.
The orthomolecular treatment of cancer, II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer
Chem.-Biol. Interact.
(1974)

There are more references available in the full text version of this article.

Cited by (73)

Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy
2021, Redox Biology
There is a rapidly growing body of literature supporting the notion that differential oxidative metabolism in cancer versus normal cells represents a metabolic frailty that can be exploited to open a therapeutic window into cancer therapy. These cancer cell-specific metabolic frailties may be amenable to manipulation with non-toxic small molecule redox active compounds traditionally thought to be antioxidants. In this review we describe the potential mechanisms and clinical applicability in cancer therapy of four small molecule redox active agents: melatonin, vitamin E, selenium, and vitamin C. Each has shown the potential to have pro-oxidant effects in cancer cells while retaining antioxidant activity in normal cells. This dichotomy can be exploited to improve responses to radiation and chemotherapy by opening a therapeutic window based on a testable biochemical rationale amenable to confirmation with biomarker studies during clinical trials. Thus, the unique pro-oxidant/antioxidant properties of melatonin, vitamin E, selenium, and vitamin C have the potential to act as effective adjuvants to traditional cancer therapies, thereby improving cancer patient outcomes.
Intravenous vitamin C for reduction of cytokines storm in acute respiratory distress syndrome
2020, PharmaNutrition
Citation Excerpt :
Despite this important observation, a lack of control study prevented making any conclusion on the health benefits of ascorbic acid treatment. From a limited study published in 1975, it is apparent that one of the patients experienced tumor regression [60]. The patient who had reticulum cell sarcoma exhibited improvement due to the treatment with ascorbic acid.
The recent outbreak of Covid19 has required urgent treatments for numerous patients. No suitable vaccines or antivirals are available for Covid19. The efficiency against Covid19 of WHO therapies of choice, that are two antivirals developed for other pathologies, is controversial. Therefore, alternative approaches are required. Intravenous (IV) Vitamin C (Vit-C) has emerged as one of the other alternatives for this purpose. Here we review the effects of IV Vit-C on the immune system response, the antiviral properties of IV Vit-C, and finally the antioxidant properties of IV Vit-C to specifically address the cytokines' storm characteristic of the Acute Respiratory Distress Syndrome (ARDS) that occur in the later cycle of the Covid19 infectious disease.
2-O-β-D-glucopyranosyl- <inf>L</inf> -ascorbic acid, a novel vitamin C derivative from Lycium barbarum, prevents oxidative stress
2019, Redox Biology
Citation Excerpt :
These results suggested that AA-2αG and AA-2βG may not quench free radicals through AA as intermediate but either through the activation of the cellular defense system or formation of covalent adduct with free radicals. High AA concentration (10 g/day) is required to achieve the antioxidant capacity in overcoming its fast oxidation rate in the clinic [31]. High AA concentration is associated with increased kidney stone incidence and considerable renal, cardiac, and metabolic toxicity [8].
Reducing agents are crucial for the management of maladaptive inflammation-induced macrophage death and hematopoietic toxicity of chemotherapy. 2-O-β-d-glucopyranosyl-_l-ascorbic acid (AA-2βG), a unique AA (or vitamin C) derivative identified in Lycium barbarum, exhibited enhanced free radical scavenging activity compared with AA and its synthetic derivative AA-2αG. AA-2βG protected hydrogen peroxide-induced cell death in murine macrophage RAW264.7 cells. Treatment with AA-2βG eliminated oxidative stress and the ratio of cellular glutathione to glutathione disulfide more effectively than AA and AA-2αG. AA-2βG also significantly reduced the fluorescent intensity of DCFH-DA triggered by chemotherapeutic agent camptotehcin-11 but not fluorouracil. AA, AA-2αG, and AA-2βG significantly decreased Keap-1expression, and increased the expression levels of nuclear factor E2-related factor 2 (Nrf2) and heme oxygenase-1. All compounds triggered the nuclear translocation of Nrf2, while the ability of AA-2βG to enhance the Nrf2-DNA binding affinity was approximately two fold as those of AA and AA-2αG. Sodium ascorbate cotransporters (SVCT) inhibitors, sulfinpyrazone, phloretin, and 3-O-methyglucose, potently abrogated the free radical scavenging activities of AA, AA-2αG, and AA-2βG. The cellular uptake efficacy of AA-2αG and AA-2βG was less than 10% of AA, while the inhibition of SVCT with sulfinpyrazone considerably diminished the uptake efficacy of these compounds. AA-2αG and AA-2βG are more stable in the Fenton reagents than AA. In summary, AA-2βG from L. barbarum with excellent free radical scavenging activity is a promising natural AA derivative for further pharmacological evaluation.
Manipulating redox active metal metabolism to enhance cancer therapy
2019, Improving the Therapeutic Ratio in Head and Neck Cancer
Redox active metals, including iron, play essential roles in regulating cellular growth and metabolism. Approximately 2% of cellular iron is unbound and can participate in redox reactions. This labile iron pool (LIP) is tightly regulated by cells as excess LIP can participate in Fenton chemistry reactions generating reactive oxygen species. Many malignancies have increased iron uptake resulting in increased LIPs that contribute to cancer proliferation. Iron chelation therapy reduces LIPs and slows cancer progression. Alternatively, treatment with pharmacological ascorbate further increases cancer cell LIPs thereby increasing oxidative stress. Currently multiple clinical trials are combining pharmacological ascorbate with radiation and chemotherapy in a variety of cancers. Drugs containing redox active catalytic metals are also reducing radiation and chemotherapy-induced toxicity. The superoxide dismutase mimetic, GC4419, contains a catalytically active Mn^2 + ion that dismutes superoxide radicals and protects against radiation and chemotherapy induced mucositis in head and neck cancer patients.
Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly
2018, Cancer Cell
Citation Excerpt :
There were substantial limitations, including a Scottish patient population at substantial risk for severe vitamin C deficiency/scurvy that may have been corrected by treatment; lack of definitive pathology; retrospective selective bias; and lack of adequate controls. Even so, there remains at least one exceptionally well documented case report by Cameron and colleagues of double complete regression (Cameron et al., 1975; Campbell et al., 1991). We note that exquisite sensitivity to H2O2 generated by the initial i.v. ascorbate could still explain findings, and other aforementioned limitations may also be confounders.
Vitamin C (ascorbic acid, ascorbate), despite controversy, has re-emerged as a promising anti-cancer agent. Recent knowledge of intravenous ascorbate pharmacokinetics and discovery of unexpected mechanisms of ascorbate action have spawned many investigations. Two mechanisms of anti-cancer activity with ascorbate have gained prominence: hydrogen peroxide-induced oxidative stress and DNA demethylation mediated by ten-eleven translocation enzyme activation. Here, we highlight salient aspects of the evolution of ascorbate in cancer treatment, provide insights into the pharmacokinetics of ascorbate, describe mechanisms of its anti-cancer activity in relation to the pharmacokinetics, outline promising preclinical and clinical evidence, and recommend future directions.
Combining mouse embryonic stem cells and zebrafish embryos to evaluate developmental toxicity of chemical exposure
2018, Reproductive Toxicology
Citation Excerpt :
This is in agreement with other reports which show that pre-treatment to ascorbic acid protects against various damage in zebrafish [10,43,44,53]. Several clinical studies have been conducted to investigate possible benefits of ascorbic acid as a chemotherapeutic agent [54,55]. The proposed mechanisms for ascorbate activity include apoptosis through cell cycle arrest, activation of apoptosis-inducing factor (AIF) factor, and interference with transferrin receptor and iron uptake [56–58].
The assays in this study utilize mouse embryonic stem cells (mESCs) and zebrafish embryos to evaluate the potential developmental toxicity of industrial and pharmaceutical chemicals. A set of eleven chemicals of known mammalian in vivo teratogenicity were tested in the assays and correlations to mammalian data. Using mESCs, proliferation, differentiation, and cytotoxicity of the chemicals were measured. In zebrafish embryos, lethality and the lowest effect level concentrations for morphological malformations were determined. Clustering of the assays based on frequency of affected assays resulted in a ranking of the test compounds that correlated to in vivo rodent data (R = 0.88, P < 0.001). We conclude that the combination of ESC- and zebrafish-based assays provides a valuable platform for the prioritization of pharmaceutical and industrial chemicals for further testing of developmental toxicity in rodents.

View all citing articles on Scopus

: Supported by a Research Grant from the Secretary of State for Scotland and the Educational Foundation of America.

^a: Consultant Surgeon, Dunbartonshire Hospitals and Fellow of the Linus Pauling Institute (formerly the Institute of Orthomolecular Medicine).

^b: Consultant Physicians, Lanarkshire Hospitals.

View full text

The orthomolecular treatment of cancer: III. Reticulum cell sarcoma: Double complete regression induced by high-dose ascorbic acid therapy

Abstract

Lancet

Chem.-Biol. Interact.

Chem.-Biol. Interact.